Status | Study |
Active, not recruiting |
Study Name: Busulfan, Melphalan, Topotecan Hydrochloride, and a Stem Cell Transplant in Treating Patients With Newly Diagnosed or Relapsed Solid Tumor Condition: Solid Tumor Adult Central Nervous System Germ Cell Tumor A Date: 2008-03-18 Interventions: Drug: busulfan Given IV |
Completed |
Study Name: Ispinesib in Treating Young Patients With Relapsed or Refractory Solid Tumors or Lymphoma Condition: Childhood Burkitt Lymphoma Childhood Central Nervous System Germ Cell Tumor Date: 2006-08-10 Interventions: Drug: ispinesib Given IV |
Completed |
Study Name: AZD2171 in Treating Young Patients With Recurrent, Progressive, or Refractory Primary CNS Tumors Condition: Childhood Atypical Teratoid/Rhabdoid Tumor Childhood Central Nervous System Germ Cell Tumor Date: 2006-05-16 Interventions: Drug: Cediranib Maleate Given orally Other Names: |
Terminated |
Study Name: Thiotepa and Radiation Therapy in Treating Young Patients With Newly Diagnosed Malignant Brain Tumors Condition: Brain and Central Nervous System Tumors Date: 2006-04-11 Interventions: Drug: thiotepa Procedure: adjuvant therapy |
Completed |
Study Name: Oxaliplatin and Irinotecan in Treating Young Patients With Refractory Solid Tumors or Lymphomas Condition: Childhood Burkitt Lymphoma Childhood Central Nervous System Germ Cell Tumor Date: 2005-01-07 Interventions: Drug: irinotecan hydrochloride |
Completed |
Study Name: Lenalidomide in Treating Young Patients With Recurrent, Progressive, or Refractory CNS Tumors Condition: Childhood Atypical Teratoid/Rhabdoid Tumor Childhood Central Nervous System Germ Cell Tumor Date: 2005-01-06 Interventions: Drug: lenalidomide Given PO |
Completed |
Study Name: Oxaliplatin in Treating Young Patients With Recurrent Solid Tumors That Have Not Responded to Previous Treatment Condition: Childhood Central Nervous System Germ Cell Tumor Childhood Extragonadal Germ Cell Tumor Date: 2004-09-07 Interventions: Drug: oxaliplatin Given IV Other Names: |
Completed |
Study Name: High-Dose Chemotherapy Plus Autologous Stem Cell Transplantation Compared With Intermediate-Dose Chemotherapy Plus Autologous Stem Cell Transplantation With or Without Isotretinoin in Treating Young Patients With Recurrent High-Grade Gliomas Condition: Brain Tumor Central Nervous System Tumor Date: 2004-03-08 Interventions: Biological: filgrastim Given I |
Completed |
Study Name: Erlotinib and Temozolomide in Treating Young Patients With Recurrent or Refractory Solid Tumors Condition: Previously Treated Childhood Rhabdomyosarcoma Recurrent Childhood Brain Tumor Date: 2004-02-10 Interventions: Drug: erlotinib hydrochloride |
Completed |
Study Name: Tipifarnib in Treating Young Patients With Recurrent or Progressive High-Grade Glioma, Medulloblastoma, Primitive Neuroectodermal Tumor, or Brain Stem Glioma Condition: Childhood High-grade Cerebral Astrocytoma Childhood Oligodendroglioma Date: 2003-10-03 Interventions: Drug: tipifarnib Given orally |